Leidos to provide support services for the CDC’s National Healthcare Safety Network
(Reston, Va.) Nov. 4, 2019 – Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, has been awarded a new task order by the Centers for Disease Control and Prevention (CDC) to provide support services for the National Healthcare Safety Network (NHSN). The single-award, time and materials task order has a one-year base period of performance, followed by four one-year options, and a total approximate value of $60 million if all options are exercised. Work will be performed in Atlanta.
The CDC’s National Healthcare Safety Network is the nation’s most widely used healthcare-associated infection (HAI) tracking system. HAIs affect millions annually in the United States causing injury and death. In addition, costs to healthcare systems alone run into the billions of dollars. Under the task order, Leidos will provide full product lifecycle support for the NHSN system including product management, architecture, design, development, testing, deployment, maintenance, user support, message processing, documentation, and project management. The Leidos team will also provide support for HAI protocol development; training on HAI definitions and the use of NHSN; and data quality management best practices to support HAI surveillance and data reporting.
“Reducing HAI morbidity and mortality is both an economic and a moral imperative,” said Doreen Cohen, senior vice president of Leidos Government Health and Safety Solutions. “This important work further cements Leidos’ position supporting our customers’ missions at the intersection of health, science, and technology.”
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company’s 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $10.19 billion for the fiscal year ended December 28, 2018. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company’s Annual Report on Form 10-K for the period ended December 28, 2018, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.